Chicago Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $936K | Sell |
2,419
-8
| -0.3% | -$2.97K | 0.02% | 212 |
|
|
2026
Q1 | $711K | Buy |
2,427
+8
| +0.3% | +$2.63K | 0.02% | 233 |
|
|
2025
Q4 | $848K | Hold |
2,419
| – | – | 0.02% | 216 |
|
|
2025
Q3 | $782K | Buy |
2,419
+230
| +11% | +$71.5K | 0.02% | 214 |
|
|
2025
Q2 | $851K | Buy |
2,189
+20
| +0.9% | +$8.04K | 0.02% | 200 |
|
|
2025
Q1 | $943K | Hold |
2,169
| – | – | 0.03% | 180 |
|
|
2024
Q4 | $800K | Buy |
2,169
+145
| +7% | +$60.7K | 0.02% | 186 |
|
|
2024
Q3 | $1.05M | Sell |
2,024
-12
| -0.6% | -$6.41K | 0.03% | 160 |
|
|
2024
Q2 | $1.1M | Sell |
2,036
-4,336
| -68% | -$2.29M | 0.03% | 158 |
|
|
2024
Q1 | $3.3M | Sell |
6,372
-656
| -9% | -$326K | 0.1% | 98 |
|
|
2023
Q4 | $3.31M | Buy |
7,028
+4,986
| +244% | +$2.31M | 0.12% | 91 |
|
|
2023
Q3 | $889K | Hold |
2,042
| – | – | 0.04% | 109 |
|
|
2023
Q2 | $907K | Hold |
2,042
| – | – | 0.04% | 111 |
|
|
2023
Q1 | $939K | Hold |
2,042
| – | – | 0.05% | 108 |
|
|
2022
Q4 | $1.05M | Hold |
2,042
| – | – | 0.06% | 104 |
|
|
2022
Q3 | $928K | Buy |
2,042
+6
| +0.3% | +$2.87K | 0.05% | 107 |
|
|
2022
Q2 | $983K | Hold |
2,036
| – | – | 0.05% | 113 |
|
|
2022
Q1 | $1M | Hold |
2,036
| – | – | 0.04% | 120 |
|
|
2021
Q4 | $944K | Hold |
2,036
| – | – | 0.04% | 129 |
|
|
2021
Q3 | $759K | Hold |
2,036
| – | – | 0.03% | 143 |
|
|
2021
Q2 | $777K | Hold |
2,036
| – | – | 0.03% | 140 |
|
|
2021
Q1 | $731K | Hold |
2,036
| – | – | 0.03% | 133 |
|
|
2020
Q4 | $654K | Buy |
2,036
+36
| +2% | +$11K | 0.03% | 143 |
|
|
2020
Q3 | $537K | Hold |
2,000
| – | – | 0.03% | 151 |
|
|
2020
Q2 | $526K | Hold |
2,000
| – | – | 0.03% | 149 |
|
|
2020
Q1 | $454K | Hold |
2,000
| – | – | 0.04% | 140 |
|
|
2019
Q4 | $604K | Hold |
2,000
| – | – | 0.04% | 147 |
|
|
2019
Q3 | $480K | Hold |
2,000
| – | – | 0.03% | 158 |
|
|
2019
Q2 | $564K | Hold |
2,000
| – | – | 0.04% | 149 |
|
|
2019
Q1 | $574K | Hold |
2,000
| – | – | 0.04% | 138 |
|
|
2018
Q4 | $525K | Hold |
2,000
| – | – | 0.04% | 138 |
|
|
2018
Q3 | $548K | Hold |
2,000
| – | – | 0.04% | 143 |
|
|
2018
Q2 | $476K | Hold |
2,000
| – | – | 0.04% | 154 |
|
|
2018
Q1 | $439K | Buy |
+2,000
| New | +$470K | 0.06% | 110 |
|
Other funds holding ELV
Chicago Capital's ELV Position: Q2 2026 in Review
Chicago Capital reduced its Elevance Health (ELV) stake by 0.33% in Q2 2026, selling an estimated $2.97K and leaving 2,419 shares worth $936K. The position accounts for 0.02% of the portfolio, ranked #212.
Chicago Capital first reported a position in ELV in Q1 2018 and has held it in 34 quarters since. The position peaked at $3.31M in Q4 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Chicago Capital held 2,419 shares of Elevance Health worth $936K as of Q2 2026.
- Chicago Capital sold 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
- Elevance Health made up 0.02% of Chicago Capital's portfolio in Q2 2026, its #212 holding.
- Chicago Capital first reported a position in Elevance Health in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's Elevance Health position peaked at $3.31M in Q4 2023.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.